<DOC>
	<DOC>NCT01424904</DOC>
	<brief_summary>The purpose of this research is to evaluate the effects of DGB-01 on performance of a 40‚Äêkm time trial in trained male cyclists. The investigators believe that DGB-01 will improve performance on the time trial as measured by a reduction in the amount of time required to complete the distance, using a computerized cycle ergometer.</brief_summary>
	<brief_title>DGB-01 Effects on Endurance Exercise</brief_title>
	<detailed_description />
	<mesh_term>Fatigue</mesh_term>
	<criteria>Healthy males who are trained cyclists with a maximal oxygen uptake relative to body weight equal to or greater than 45 ml O2/kg/min. Subjects must be in the competitive phase of their annual training cycle. Between ages of 1860 Availability commitment of the subject/expected participation in the study for 97 days. Specific allergy to milk proteins (this is different from lactose intolerance) Use of immunosuppressive medication in the case of organ transplants Planned surgeries. Kidney disorders Use of antihypertensive medications Cardiovascular disease Abnormal BUN, creatinine, hemoglobin, or hematocrit Body weight greater than 285 pounds A proteinrestricted diet Subjects currently using dry whey protein supplements, Nacetylcysteine, or alphalipoic acid supplements. The washout period is 1 month for any of these supplements. All medications that can interfere with muscle mass such as corticosteroids (e.g. prednisone), testosterone replacement or anabolic drugs such as Megace</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>Ergogenic aid</keyword>
	<keyword>Exercise endurance</keyword>
	<keyword>High performance</keyword>
	<keyword>Time trial performance</keyword>
	<keyword>Glutathione</keyword>
</DOC>